DocGo Inc. (NASDAQ:DCGO) General Counsel Sells $102,510.72 in Stock

DocGo Inc. (NASDAQ:DCGO) General Counsel Ely D. Tendler sold 23,088 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now directly owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

DocGo Stock Performance

NASDAQ DCGO traded up $0.20 during trading hours on Monday, hitting $4.49. 658,668 shares of the company’s stock were exchanged, compared to its average volume of 972,521. The business’s 50 day moving average is $3.83 and its 200-day moving average is $3.50. DocGo Inc. has a 12-month low of $2.75 and a 12-month high of $5.70. The firm has a market capitalization of $458.21 million, a P/E ratio of 16.04, a price-to-earnings-growth ratio of 3.81 and a beta of 0.98.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. nVerses Capital LLC increased its position in DocGo by 151.5% during the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock worth $26,000 after purchasing an additional 5,000 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of DocGo by 693.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock worth $37,000 after buying an additional 10,565 shares during the last quarter. Centiva Capital LP purchased a new position in shares of DocGo in the 3rd quarter worth $43,000. Intech Investment Management LLC purchased a new position in shares of DocGo in the 3rd quarter worth $62,000. Finally, SG Americas Securities LLC acquired a new position in DocGo in the second quarter valued at $60,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald reiterated an “overweight” rating and set a $5.00 price target on shares of DocGo in a report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $6.10.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.